全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Epidemiological and Histopathological Profiles of Pediatric Rhabdomyosarcoma in Two Anatomy and Pathological Cytology Laboratories in Antananarivo Chu/Jra and Salfa Andohalo

DOI: 10.4236/ojpathology.2025.152008, PP. 90-97

Keywords: Anatomy Pathology, Pediatric Cancer, Pediatric Rhabdomyosarcoma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction: Rhabdomyosarcoma is rare in children under 15 years of age. In Madagascar, there are few studies concerning rhabdomyosarcoma. The aim of this study was to investigate the epidemiological and histological aspects of pediatric rhabdomyosarcomas in two Antananarivo pathological anatomy and cytology laboratories: CHU-JRA and SALFA Andohalo. Materials and Method: This is a retrospective, descriptive, bicentric study over a 10-year period from January 2010 to December 2019 of rhabdomyosarcoma cases diagnosed in the paediatric population. The parameters studied were age, gender, location and histological diagnosis. Results: We collected 37 cases. Patients ranged in age from 08 months to 15 years, with a mean age of 6.28 years. The sex ratio was 1.46. The most frequently encountered histological types were embryonal rhabdomyosarcoma (56.75%), followed by alveolar type (27.03%), spindle cell rhabdomyosarcoma (08.11%) and botryoid type (08.11%). Localizations in order of frequency were head and neck (24.32%), genitourinary regions (24.32%), limbs (18.92%), buttocks (18.92%), trunk (10.52%) and secondary localizations (2.70%). Conclusion: Pediatric rhabdomyosarcoma is rare. Localizations are mainly head and neck and genitourinary tract. The lack of immunohistochemical examination is a limitation of this study.

References

[1]  Hessissen, L., Kanouni, L., Kili, A., Nachef, M.N., El Khorassani, M., Benjaafar, N., et al. (2009) Pediatric rhabdomyosarcoma in Morocco. Pediatric Blood & Cancer, 54, 25-28.
https://doi.org/10.1002/pbc.22173
[2]  Sommelet, D., Pinkerton, R., Brunat-Mentigny, M., Farsi, F., Martel, I., Philip, T., et al. (1998) Standards, Options and Recommendations (SOR) for Clinical Care of Rhabdomyosarcoma (RMS) and Other Soft Tissue Sarcoma in Children. Federation of the French Cancer Centers. French Society of Pediatric Oncology. Bulletin du Cancer (Paris), 85, 1015-1042.
[3]  Rasoloniana, A.R. (2014) Rhabdomyosarcome vulvaire chez l’enfant. Thesis, Médecine Humaine, 48 p.
[4]  Ranjevamalala, A.D. (2008) Le rhabdomyosarcome vulvaire chez l’enfant à propos d’un cas. Thesis, Médecine Humaine, 45 p.
[5]  D’Andon, A., Hartmann, O. and Vassal, G. (2003) Tumeurs mésenchymateuses malignes ou sarcomes des parties molles. Institut Gustave Roussy, 1-14.
[6]  Maurer, H.M., Crist, W., Lawrence, W., Ragab, A.H., Raney, R.B., Webber, B., et al. (1988) The Intergroup Rhabdomyosarcoma Study-I. A Final Report. Cancer, 61, 209-220.
https://doi.org/10.1002/1097-0142(19880115)61:2<209::aid-cncr2820610202>3.0.co;2-l
[7]  Gizaw, N.Y., Kallio, P., Punger, T., Gucciardo, E., Haglund, C., Böhling, T., et al. (2022) PROX1 Transcription Factor Controls Rhabdomyosarcoma Growth, Stemness, Myogenic Properties and Therapeutic Targets. Proceedings of the National Academy of Sciences of the United States of America, 119, e2116220119.
https://doi.org/10.1073/pnas.2116220119
[8]  Newton, W.A., Gehan, E.A., Webber, B.L., Marsden, H.B., van Unnik, A.J.M., Hamoudi, A.B., et al. (1995) Classification of Rhabdomyosarcomas and Related Sarcomas. Pathologic Aspects and Proposal for a New Classification—An Intergroup Rhabdomyosarcoma Study. Cancer, 76, 1073-1085.
https://doi.org/10.1002/1097-0142(19950915)76:6<1073::aid-cncr2820760624>3.0.co;2-l
[9]  Perez, E.A., Kassira, N., Cheung, M.C., Koniaris, L.G., Neville, H.L. and Sola, J.E. (2011) Rhabdomyosarcoma in Children: A SEER Population Based Study. Journal of Surgical Research, 170, e243-e251.
https://doi.org/10.1016/j.jss.2011.03.001
[10]  Skapek, S.X., Ferrari, A., Gupta, A.A., Lupo, P.J., Butler, E., Shipley, J., et al. (2019) Rhabdomyosarcoma. Nature Reviews Disease Primers, 5, Article No. 1.
https://doi.org/10.1038/s41572-018-0051-2
[11]  Bergeron, C., Ranchere-Vince, D. and Berard-Marec, P. (2002) Update on Rhabdomyosarcomas in Children. Bulletin du Cancer (Paris), 89, 108-112.
[12]  Habibi, L. (2017) Etude du rhabdomyosarcome chez l’enfant dans le service d’oncologie et hématologie pédiatrique. Master’s Theis, Oncologie Pédiatrique, 123p.
[13]  Tsokos, M., Webber, B.L., Parham, D.M., Wesley, R.A., Miser, A., Miser, J.S., et al. (1992) Rhabdomyosarcoma. A New Classification Scheme Related to Prognosis. Archives of Pathology & Laboratory Medicine, 116, 847-855.
[14]  Badr, M.A., Al-Tonbary, Y.A., Mansour, A.K., Hassan, T.H., Beshir, M.R., Darwish, A., et al. (2012) Epidemiological Characteristics and Survival Studies of Rhabdomyosarcoma in East Egypt: A Five-Year Multicenter Study. ISRN Oncology, 2012, Article ID: 674523.
https://doi.org/10.5402/2012/674523
[15]  Ruymann, F.B., Maddux, H.R., Ragab, A., Soule, E.H., Palmer, N., Beltangady, M., et al. (1988) Congenital Anomalies Associated with Rhabdomyosarcoma: An Autopsy Study of 115 Cases. A Report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children’s Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children’s Cancer Study Group, and the Pediatric Intergroup Statistical Center). Medical and Pediatric Oncology, 16, 33-39.
https://doi.org/10.1002/mpo.2950160109
[16]  Flamant, F., Rodary, C., Rey, A., Praquin, M.-., Sommelet, D., Quintana, E., et al. (1998) Treatment of Non-Metastatic Rhabdomyosarcomas in Childhood and Adolescence. Results of the Second Study of the International Society of Paediatric Oncology: MMT84. European Journal of Cancer, 34, 1050-1062.
https://doi.org/10.1016/s0959-8049(98)00024-0
[17]  Molenaar, W.M., Oosterhuis, J.W., Oosterhuis, A.M. and Ramaekers, F.C.S. (1985) Mesenchymal and Muscle-Specific Intermediate Filaments (Vimentin and Desmin) in Relation to Differentiation in Childhood Rhabdomyosarcomas. Human Pathology, 16, 838-843.
https://doi.org/10.1016/s0046-8177(85)80256-2
[18]  Kumar, S., Perlman, E., Harris, C.A., Raffeld, M. and Tsokos, M. (2000) Myogenin Is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues. Modern Pathology, 13, 988-993.
https://doi.org/10.1038/modpathol.3880179

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133